RC-3095

Biorbyt

RC-3095

10

138147-78-1

Research Use Only

C56H79N15O9 xC2HF3O2

1220.344923

RC-3095 is a gastrin-releasing peptide receptor antagonist, synergizes with gemcitabine to inhibit the growth of human pancreatic cancer CFPAC-1 in vitro and in vivo. RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. RC3095 inhibits tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.R,BRS-1) antagonist.

NC(CC[C@@H](C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](CN[C@H](C(=O)N)CC(C)C)CC(C)C)=O)CC1=CN=CN1)=O)=O)C(C)C)=O)C)=O)=O)NC([C@@H]1NCC2=C(C3=CC=CC=C3N2)C1)=O)=O.FC(C(=O)O)(F)F

12352200